Abstracts tagged "respiratory disease and systemic sclerosis"

Abstract Number: 2003 • 2017 ACR/ARHP Annual Meeting
18 FDG PET/CT Predicts Decline in Functional Respiratory TESTS in Systemic Sclerosis Patients but NOT in Rheumatoid Arthritis Patients
Jorge Juan Fragio Gil¹, Jose Ivorra Cortes¹, Manuela Martinez Frances², Jose Luis Loaiza Gongora³, Juan José Alegre⁴, Marta Garijo Bufort⁵, Susana Herrera Lara⁶, Inmaculada Chalmeta Verdejo¹, Luis Gonzalez Puig¹, Rosa Negueroles Albuixech¹, Cristina Alcañiz Escandell¹, Karla Arevalo Ruales¹, Ines Canovas Olmos¹, Carlos Feced Olmos¹, Roxana Gonzalez Mazario¹, Elena Grau Garcia¹, Eztizen Labrador Sanchez¹, Isabel Martinez Cordellat¹, Carmen Najera Herranz¹, Jose Eloy Oller Rodriguez¹, Francisco Miguel Ortiz-Sanjuán¹, Elvira Vicens Bernabeu¹, Marta De la Rubia Navarro¹, David Hervás Marín⁷ and Jose Andres Roman Ivorra¹, ¹Rheumatology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ²Pneumology Department. Hospital Universitario y Politecnico La Fe, Valencia, Spain, ³Nuclear Medicine Department. HUP La Fe, Valencia, Spain, ⁴Sección de Reumatología Hospital Universitario Dr Peset Valencia, Valencia, Spain, ⁵Rheumatology Unit. Hospital de León, León, Spain, ⁶Pneumology Department. Hospital Dr. Peset, Valencia, Spain, ⁷Biostatistics Unit. IIS La Fe, Valencia, Spain
Background/Purpose: Interstitial lung diseases (ILD) are a group of illnesses that often complicate connective tissue diseases (CTD) such as rheumatoid arthritis (RA) or systemic sclerosis…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].